Corient Private Wealth
GILD icon

Corient Private Wealth’s Gilead Sciences GILD Stock Holding History

Corient Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.1M Sell
619,389
-827,837
-57% -$116M 0.12% 157
2025
Q4 		$147M Buy
1,447,226
+875,521
+153% +$106M 0.1% 195
2025
Q3 		$63.5M Sell
571,705
-24,396
-4% -$2.77M 0.1% 197
2025
Q2 		$66.1M Sell
596,101
-951
-0.2% -$101K 0.09% 197
2025
Q1 		$66.9M Sell
597,052
-35,751
-6% -$3.69M 0.11% 183
2024
Q4 		$58.5M Buy
632,803
+1,163
+0.2% +$105K 0.1% 201
2024
Q3 		$53M Sell
631,640
-27,997
-4% -$2.14M 0.08% 232
2024
Q2 		$45.3M Sell
659,637
-35,385
-5% -$2.36M 0.08% 236
2024
Q1 		$50.9M Sell
695,022
-31,957
-4% -$2.46M 0.09% 219
2023
Q4 		$58.9M Sell
726,979
-32,851
-4% -$2.56M 0.11% 193
2023
Q3 		$56.9M Sell
759,830
-17,414
-2% -$1.34M 0.13% 169
2023
Q2 		$59.9M Buy
777,244
+257,810
+50% +$20.6M 0.14% 156
2023
Q1 		$43.1M Buy
519,434
+166,913
+47% +$13.8M 0.12% 174
2022
Q4 		$30.3M Buy
+352,521
New +$27.9M 0.11% 199

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Corient Private Wealth's GILD Position: Q1 2026 in Review

Corient Private Wealth reduced its Gilead Sciences (GILD) stake by 57% in Q1 2026, selling an estimated $116M and leaving 619,389 shares worth $86.1M. The position accounts for 0.12% of the portfolio, ranked #157.

Corient Private Wealth first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $147M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Corient Private Wealth held 619,389 shares of Gilead Sciences worth $86.1M as of Q1 2026.
  • Corient Private Wealth sold 827,837 Gilead Sciences shares in Q1 2026, an estimated $116M.
  • Gilead Sciences made up 0.12% of Corient Private Wealth's portfolio in Q1 2026, its #157 holding.
  • Corient Private Wealth first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Gilead Sciences position peaked at $147M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.